API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217396
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-12-2023-4244.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-gets-usfda-nod-to-market-generic-medication-to-treat-high-blood-pressure/articleshow/98266468.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-6-2022-1657105109.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/strides-pharma-recalls-over-6-lakh-bottles-of-blood-pressure-treatment-tablets-in-us/articleshow/92158435.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-8-2022-1654674832.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-june-01-2022-1654158193.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-11-2022-1652250109.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-4-2022-1651646484.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-auro-pharmas-losartan-2550100mg-tablets-1633945560.pdf
https://www.newswire.ca/news-releases/advisory-multiple-lots-of-irbesartan-losartan-and-valsartan-drugs-recalled-due-to-azido-impurity-824128492.html
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-sandoz-canadas-losartan-1632832579.pdf
https://www.swissmedic.ch/swissmedic/en/home/humanarzneimittel/market-surveillance/qualitaetsmaengel-und-chargenrueckrufe/batch-recalls/chargenrueckruf-losartan-mepha-lactab.html
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-sanis-losartan-1632832674.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-tevas-losartan-1630401664.pdf
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75707r-eng.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75693r-eng.php
https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75687r-eng.php
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-14-2020-1602673736.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-for-week-of-october-7-2020-1602054141.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-2-2020-1599053980.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-22-2020-1587564893.pdf
https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure
https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/torrent-pharma-recalls-74k-bottles-of-hypertension-drug-from-us/articleshow/71562796.cms
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-october-9-2019-1570607610.pdf
https://www.pharmacompass.com/pdf/news/torrent-pharmaceuticals-limited-expands-voluntary-nationwide-recall-of-losartan-potassium-tablets-1569033044.pdf
https://www.cnbc.com/2019/09/13/fda-finds-impurity-in-heartburn-medicine-zantac-that-could-cause-cancer.html
https://www.fiercepharma.com/manufacturing/aurobindo-recalls-mislabeled-statin-tablets-off-u-s-market
https://www.raps.org/news-and-articles/news-articles/2019/7/manufacturing-concerns-lead-fda-to-pull-31-apotex?feed=Regulatory-Focus
https://www.fiercepharma.com/manufacturing/aurobindo-gets-warning-letter-over-valsartan-recall-mess
https://www.fiercepharma.com/manufacturing/teva-recall-tainted-blood-pressure-meds-continue-to-show-up-u-s-supply
https://www.pharmacompass.com/pdf/news/teva-pharmaceuticals-usa-inc-issues-voluntary-nationwide-recall-of-gsms-inc-losartan-potassium-due-to-due-to-the-detection-of-an-impurity-n-nitroso-n-methyl-4-aminobutyric-acid-nmba-1560407242.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-29-2019-1559107900.pdf
https://www.raps.org/news-and-articles/news-articles/2019/5/fda-483s-pile-up-in-crackdown-on-sartan-manufactur
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-8-2019-1557294096.pdf
https://www.pharmacompass.com/pdf/news/vivimed-life-sciences-issues-voluntary-nationwide-recall-of-losartan-potassium-25-mg-50-mg-and-100-mg-tablets-usp-1556949904.pdf
https://www.in-pharmatechnologist.com/Article/2019/04/29/Torrent-and-Teva-recall-losartan-tablets